These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26224673)

  • 1. [Analysis of Musculoskeletal Systems and Their Diseases. Use of iPS cells in regenerative therapy and drug discovery for cartilage diseases].
    Tsumaki N
    Clin Calcium; 2015 Aug; 25(8):1162-8. PubMed ID: 26224673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [iPS cells for the generation of cartilage and for regenerative medicine and disease modeling of cartilage diseases].
    Tsumaki N
    Clin Calcium; 2016 Apr; 26(4):587-92. PubMed ID: 27013630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iPS cell technologies and cartilage regeneration.
    Tsumaki N; Okada M; Yamashita A
    Bone; 2015 Jan; 70():48-54. PubMed ID: 25026496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
    de Lázaro I; Yilmazer A; Kostarelos K
    J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells in research and therapy.
    Teoh HK; Cheong SK
    Malays J Pathol; 2012 Jun; 34(1):1-13. PubMed ID: 22870592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research for cell therapy by induced pluripotent stem cell].
    Sakurai H; Yamanaka S
    Nihon Rinsho; 2011 Dec; 69(12):2114-8. PubMed ID: 22242307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cartilage regeneration using cell reprogramming technologies].
    Tsumaki N
    Clin Calcium; 2013 Nov; 23(11):1641-8. PubMed ID: 24162605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regenerative medicine for cartilage defect in rheumatic disease].
    Takahashi N; Ishiguro N
    Clin Calcium; 2015 Dec; 25(12):1801-7. PubMed ID: 26608855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells: a new technology to study human diseases.
    Vitale AM; Wolvetang E; Mackay-Sim A
    Int J Biochem Cell Biol; 2011 Jun; 43(6):843-6. PubMed ID: 21458591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current topics of regenerative medicine: joint-synovium mesenchymal stem cells for cartilage regeneration].
    Katano N; Muneta T; Sekiya Ichiro
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Jun; 118(6):723-7. PubMed ID: 26567386
    [No Abstract]   [Full Text] [Related]  

  • 14. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery.
    Rowntree RK; McNeish JD
    Regen Med; 2010 Jul; 5(4):557-68. PubMed ID: 20632859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
    Pan G; Wang T; Yao H; Pei D
    Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient hepatic differentiation from human iPS cells by gene transfer.
    Kawabata K; Inamura M; Mizuguchi H
    Methods Mol Biol; 2012; 826():115-24. PubMed ID: 22167644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commercialization challenges associated with induced pluripotent stem cell-based products.
    Smith D
    Regen Med; 2010 Jul; 5(4):593-603. PubMed ID: 20632862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling human neurological disorders with induced pluripotent stem cells.
    Imaizumi Y; Okano H
    J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentialities of induced pluripotent stem (iPS) cells for treatment of diseases.
    Chakraborty C; Shah KD; Cao WG; Hsu CH; Wen ZH; Lin CS
    Curr Mol Med; 2010 Nov; 10(8):756-62. PubMed ID: 20937020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.